Galapagos NV

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 0.52%130.400.0%$2978.05m
BNGOBioNano Genomics, Inc. 21.01%8.410.0%$1423.93m
GILDGilead Sciences, Inc. 0.40%62.651.0%$653.98m
AMGNAmgen, Inc. -0.10%241.431.3%$585.17m
CRSPCRISPR Therapeutics AG 1.40%212.970.6%$547.40m
ALXNAlexion Pharmaceuticals, Inc. 0.41%157.292.0%$544.88m
NVAXNovavax, Inc. 1.42%131.8292.9%$502.25m
REGNRegeneron Pharmaceuticals, Inc. 0.65%521.292.7%$484.53m
ILMNIllumina, Inc. 2.82%381.493.5%$368.67m
BIIBBiogen, Inc. 0.54%281.801.7%$365.87m
VRTXVertex Pharmaceuticals, Inc. -0.01%226.091.9%$344.39m
BNTXBioNTech SE -2.21%103.510.0%$330.70m
SRPTSarepta Therapeutics, Inc. 1.61%91.3513.8%$288.18m
OCGNOcugen, Inc. 6.45%2.320.0%$287.47m
EXASEXACT Sciences Corp. 1.17%149.0119.6%$256.12m

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.